Table 2.

Efficacy outcomes of 23 patients with B-ALL.

Efficacy Outcome	n	%
No. of patients who achieved MRD-, n (%)	3 of 3	100
Response in first cycle	2 of 3	67
Response in two cycles	1 of 3	33
No. of patients proceeding to HSCT	4 of 23	17
No. of patients proceeding to maintenance therapy, n (%)	16 of 23	78

n, number; MRD, minimal residual disease; HSCT, hematopoietic stem-cell transplantation.